Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• Successful anticancer immune responses are crucial for treating advanced cancers.
• Identifying key mediators of these responses can improve patient outcomes.

Purpose of the Study:

• To investigate the role of ferroptosis in immune-mediated melanoma regression.
• To explore the potential of modulating ferroptosis to enhance cancer immunotherapy.

Main Methods:

• Single-cell RNA sequencing of mouse melanomas with varying immune responses.
• Co-culture models of melanoma cells and CD8+ T cells.
• In vivo and ex vivo experiments using ferroptosis inducers and inhibitors with immunotherapies.
• Analysis of single-cell RNA sequencing data from human melanoma tumors.

Main Results:

• A significant ferroptosis signature was identified in mouse melanomas undergoing immune-mediated regression.
• Ferroptosis inducers and inhibitors modulated anti-melanoma immune responses when combined with immunotherapies.
• CD8+ T cells induced ferroptosis in melanoma cells by downregulating glutathione peroxidase 4 (GPX4) expression.
• Direct cell-cell contact was essential for sustained GPX4 downregulation and ferroptotic cell death.
• Human melanoma tumors responding to immunotherapy exhibited a similar ferroptosis signature to the mouse model.

Conclusions:

• Ferroptosis plays a critical role in stimulating antitumor immunity against melanoma.
• Modulating ferroptosis presents a promising strategy for enhancing the efficacy of cancer immunotherapies.